Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- VisCardia Inc.
- Study ID
- NCT06552637
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Synchronized Diaphragmatic Stimulation — DEVICEImplantable Pulse Generator system providing cardiac-gaited stimulation of the diaphragm and thereby influence cardiovascular properties relevant in heart failure.
Study Details
RECOVER HF is a clinical study designed to evaluate the safety and efficacy of Synchronized Diaphragmatic Stimulation delivered using the VisONE System in the treatment of patients with heart failure.
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 270 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Device and Medical Management* Subjects will be implanted with the VisONE System programmed to deliver SDS (Therapy On) and receive optimal, stable, Guideline Directed Medical Therapy (GDMT) for heart failure (American Heart Association \[AHA\] / American College of Cardiology \[ACC\] guidelines) including those drugs to be determined by the subject's physician * Assigned Interventions: * Device: VisONE System (SDS) * Drug: Medical Management
- Sham Comparator: Medical Management* Subjects will be implanted with the VisONE System programmed not to deliver SDS (Therapy Off) and receive optimal, stable, Guideline Directed Medical Therapy (GDMT) for heart failure (American Heart Association \[AHA\] / American College of Cardiology \[ACC\] guidelines) including those drugs to be determined by the subject's physician * Assigned Interventions: * Drug: Medical Management
Primary Outcome Measure
Left ventricular End-Systolic Volume (LVESV) [ Time Frame: 6 months ]
Central Contacts
- Patricia Arand, Ph.D.5034313823
- Peter Bauer, Ph.D.5034313824
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Aditya Parikh, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Philadelphia, PA
By condition
By specialty
By research site
Related Studies
- Left vs Left Randomized Clinical TrialRecruiting · Baylor College of Medicine · Gilbert, Arizona
- Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPHASE3 · Recruiting · Cytokinetics · Alexander City, Alabama
- Biomechanical Precision Medicine Registry for Patients With and Without Heart FailureRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Real-Time Monitoring of Heart Failure Across the Yale New Haven Health SystemRecruiting · Yale University · New Haven, Connecticut